Question 1

What are the most cited papers from Eli Lilly (Switzerland)?

Accepted Answer

The most cited paper from Eli Lilly (Switzerland) is "European registry on patients with ST-elevation myocardial infarction transferred for mechanical reperfusion with a special focus on early administration of abciximab—EUROTRANSFER Registry" (Dariusz Dudek, Zbigniew Siudak, Magnus Janzon et al., 2008), with 70 citations. Next come "Early versus periprocedural administration of abciximab for primary angioplasty: A pooled analysis of 6 studies" (58) and "A Class Comparison of Medication Persistence in People with Type 2 Diabetes: A Retrospective Observational Study" (48).

Question 2

Which research topics does Eli Lilly (Switzerland) publish most on?

Accepted Answer

By volume in 2022-now: Medical Imaging Techniques and Applications, Rheumatoid Arthritis Research and Therapies, Inflammatory Bowel Disease and Tuberculosis Research and Epidemiology.

Question 3

Which fields of science does Eli Lilly (Switzerland) work in?

Accepted Answer

In all years, 66% of research at Eli Lilly (Switzerland) is in Health Sciences, 24% in Life Sciences. Its largest fields are Medicine (58%), Biochemistry, Genetics and Molecular Biology (9%), Health Professions (7%). It does 2.0× the world's share of Health Sciences.

Question 4

Is Eli Lilly (Switzerland)'s research output growing?

Accepted Answer

Output in 2022-2025 was 44% higher than in 2018-2021.